PortfoliosLab logoPortfoliosLab logo
MDT vs. RHHBY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MDT vs. RHHBY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medtronic plc (MDT) and Roche Holding AG (RHHBY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MDT achieves a -15.83% return, which is significantly lower than RHHBY's 3.24% return. Over the past 10 years, MDT has underperformed RHHBY with an annualized return of 2.00%, while RHHBY has yielded a comparatively higher 8.27% annualized return.


MDT

1D
-0.16%
1M
5.24%
YTD
-15.83%
6M
-18.44%
1Y
-6.49%
3Y*
1.02%
5Y*
-5.47%
10Y*
2.00%

RHHBY

1D
0.58%
1M
0.76%
YTD
3.24%
6M
6.39%
1Y
26.91%
3Y*
13.95%
5Y*
5.12%
10Y*
8.27%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MDT vs. RHHBY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MDT
Medtronic plc
-15.83%24.05%0.28%9.58%-22.55%-9.79%5.70%27.34%15.18%15.90%
RHHBY
Roche Holding AG
3.24%52.86%0.23%-4.02%-22.21%20.20%9.94%33.47%2.16%14.32%

Correlation

The correlation between MDT and RHHBY is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.24

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (10Y)
Calculated over the trailing 10-year period

0.29

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2001

0.26

Fundamentals

EPS

MDT:

$3.58

RHHBY:

CHF 5.42

PE Ratio

MDT:

22.38

RHHBY:

7.59

PS Ratio

MDT:

2.91

RHHBY:

1.23

Total Revenue (TTM)

MDT:

$35.48B

RHHBY:

CHF 107.65B

Gross Profit (TTM)

MDT:

$5.78B

RHHBY:

CHF 79.28B

EBITDA (TTM)

MDT:

$7.11B

RHHBY:

CHF 31.01B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MDT vs. RHHBY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MDT
MDT Risk / Return Rank: 3030
Overall Rank
MDT Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
MDT Sortino Ratio Rank: 2424
Sortino Ratio Rank
MDT Omega Ratio Rank: 2525
Omega Ratio Rank
MDT Calmar Ratio Rank: 3636
Calmar Ratio Rank
MDT Martin Ratio Rank: 3333
Martin Ratio Rank

RHHBY
RHHBY Risk / Return Rank: 7070
Overall Rank
RHHBY Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
RHHBY Sortino Ratio Rank: 7070
Sortino Ratio Rank
RHHBY Omega Ratio Rank: 6868
Omega Ratio Rank
RHHBY Calmar Ratio Rank: 6969
Calmar Ratio Rank
RHHBY Martin Ratio Rank: 7070
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MDT vs. RHHBY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Medtronic plc (MDT) and Roche Holding AG (RHHBY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MDTRHHBYDifference
Sharpe ratioReturn per unit of total volatility

-1.29

Sortino ratioReturn per unit of downside risk

-1.95

Omega ratioGain probability vs. loss probability

0.96

1.20

-0.23

Calmar ratioReturn relative to maximum drawdown

-0.23

1.40

-1.62

Martin ratioReturn relative to average drawdown

-0.56

3.39

-3.96

MDT vs. RHHBY - Sharpe Ratio Comparison

The current MDT Sharpe Ratio is -0.31, which is lower than the RHHBY Sharpe Ratio of 0.99. The chart below compares the historical Sharpe Ratios of MDT and RHHBY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MDT vs. RHHBY - Drawdown Comparison

The maximum MDT drawdown since its inception was -57.63%, which is greater than RHHBY's maximum drawdown of -45.73%. Use the drawdown chart below to compare losses from any high point for MDT and RHHBY.


Loading charts...

Drawdown Indicators


MDTRHHBYDifference

Max Drawdown

Largest peak-to-trough decline

-57.63%

-45.73%

-11.90%

Max Drawdown (1Y)

Largest decline over 1 year

-28.90%

-19.38%

-9.52%

Max Drawdown (3Y)

Largest decline over 3 years

-28.90%

-23.46%

-5.44%

Max Drawdown (5Y)

Largest decline over 5 years

-45.10%

-40.88%

-4.22%

Max Drawdown (10Y)

Largest decline over 10 years

-45.10%

-40.88%

-4.22%

Current Drawdown

Current decline from peak

-31.23%

-12.12%

-19.11%

Average Drawdown

Average peak-to-trough decline

-16.55%

-12.84%

-3.71%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.52%

8.09%

+3.43%

Volatility

MDT vs. RHHBY - Volatility Comparison

Medtronic plc (MDT) has a higher volatility of 9.32% compared to Roche Holding AG (RHHBY) at 8.27%. This indicates that MDT's price experiences larger fluctuations and is considered to be riskier than RHHBY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MDTRHHBYDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.32%

8.27%

+1.05%

Volatility (6M)

Calculated over the trailing 6-month period

16.28%

18.31%

-2.03%

Volatility (1Y)

Calculated over the trailing 1-year period

21.07%

27.49%

-6.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.93%

23.34%

-1.41%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.25%

22.55%

+0.70%

Dividends

MDT vs. RHHBY - Dividend Comparison

MDT's dividend yield for the trailing twelve months is around 3.54%, more than RHHBY's 3.00% yield.


PositionTTM20252024202320222021202020192018201720162015
MDT
Medtronic plc
3.54%2.95%3.49%3.34%3.44%2.39%1.95%1.87%2.15%2.24%2.34%1.88%
RHHBY
Roche Holding AG
3.00%2.69%3.87%3.55%3.23%1.57%1.66%1.70%3.58%3.25%3.57%2.91%

Financials

MDT vs. RHHBY - Financials Comparison

This section allows you to compare key financial metrics between Medtronic plc and Roche Holding AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B15.00B20.00B25.00B30.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
9.02B
30.32B
(MDT) Total Revenue
(RHHBY) Total Revenue
Please note, different currencies. MDT values in USD, RHHBY values in CHF

Frequently Asked Questions


MDT and RHHBY have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MDT has higher volatility (9.32%) compared to RHHBY (8.27%). In terms of maximum drawdown, MDT dropped -57.63% vs RHHBY's -45.73%.

RHHBY currently has the higher Sharpe Ratio (0.99 vs -0.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MDT and RHHBY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer